 Sleep apnea SA affects more than 4 from general population and is largely underdiagnosed. SA can increase the occurrence of cardiovascular, endocrine and metabolic events particularly stroke, diabetes obesity. CPAP is currently the Gold Standard treatment of SA and to prevent these events, with a major clinical benefit, long term adherence to CPAP is a significant problem where a significant rate of rejection and abundance after 6 months of treatment. 